Pfizer in talks to acquire rival Wyeth
Pfizer, the US pharmaceuticals group, is in talks to acquire rival Wyeth, a deal that would create new drugs giant with a market value of around $60bn.
Pfizer Inc. will pay about $68 billion for Madison-based Wyeth, the two pharmaceutical companies announced today.